These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28266800)

  • 1. In vitro inhibition of human erythrocyte hexokinase by various hyperglycemic drugs.
    Aljamal JA; Badawneh M
    J Biochem Mol Toxicol; 2017 Aug; 31(8):. PubMed ID: 28266800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High glucose concentrations partially release hexokinase from inhibition by glucose 6-phosphate.
    Fujii S; Beutler E
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1552-4. PubMed ID: 3856279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrates of hexokinase, glucose-6-phosphate dehydrogenase, and glyceraldehyde-3-phosphate dehydrogenase prevent the inhibitory response induced by ascorbic acid/iron and dehydroascorbic acid in rabbit erythrocytes.
    Fiorani M; De Sanctis R; Scarlatti F; Stocchi V
    Arch Biochem Biophys; 1998 Aug; 356(2):159-66. PubMed ID: 9705206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannose metabolism in the human erythrocyte.
    Beutler E; Teeple L
    J Clin Invest; 1969 Mar; 48(3):461-6. PubMed ID: 5773084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and properties of buffalo (Bubalus bubalis) erythrocyte hexokinase.
    Cesar Mde C; Rosa CD; Rosa R
    Comp Biochem Physiol B Biochem Mol Biol; 1997 Oct; 118(2):395-401. PubMed ID: 9440232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of rabbit red blood cell hexokinase activity promoted in vitro by an oxygen-radical-generating system.
    Stocchi V; Biagiarelli B; Fiorani M; Palma F; Piccoli G; Cucchiarini L; Dachà M
    Arch Biochem Biophys; 1994 May; 311(1):160-7. PubMed ID: 8185313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of mammalian hexokinase-1.
    Mulichak AM; Wilson JE; Padmanabhan K; Garavito RM
    Nat Struct Biol; 1998 Jul; 5(7):555-60. PubMed ID: 9665168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human red blood cell loading with hexokinase-inactivating antibodies. An in vitro model for enzyme deficiencies.
    Magnani M; Rossi L; Bianchi M; Serafini G; Stocchi V
    Acta Haematol; 1989; 82(1):27-34. PubMed ID: 2505471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decay of mammalian hexokinase: characterization of the specific proteolytic activity.
    Murakami K; Piomelli S
    Biochim Biophys Acta; 1991 Oct; 1080(1):83-7. PubMed ID: 1657180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved metabolic properties of hexokinase-overloaded human erythrocytes.
    Magnani M; Rossi L; Bianchi M; Fornaini G; Benatti U; Guida L; Zocchi E; De Flora A
    Biochim Biophys Acta; 1988 Oct; 972(1):1-8. PubMed ID: 3179333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of hexokinase by mild insulin dependent diabetes mellitus in rat erythrocytes.
    Gupta DK; Ahmed F; Suhail M
    Indian J Exp Biol; 1997 May; 35(5):532-4. PubMed ID: 9378521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some drug effects on the activity of erythrocyte hexokinase and glucose 6-phosphate dehydrogenase enzymes in vitro and in vivo.
    Ciftçi M; Senyayla F; Ozdemir H; Büyükokuroğlu ME
    Pol J Pharmacol; 2002; 54(6):673-9. PubMed ID: 12866723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of hexokinase from Leishmania mexicana.
    Pabón MA; Cáceres AJ; Gualdrón M; Quiñones W; Avilán L; Concepción JL
    Parasitol Res; 2007 Mar; 100(4):803-10. PubMed ID: 17061112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased glucose metabolism by enzyme-loaded erythrocytes in vitro and in vivo normalization of hyperglycemia in diabetic mice.
    Rossi L; Bianchi M; Magnani M
    Biotechnol Appl Biochem; 1992 Apr; 15(2):207-16. PubMed ID: 1586460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell loading with hexokinase and hexokinase-inactivating antibodies. A new strategy for studying the role of enzymes in red cell metabolism and removal.
    Magnani M; Rossi L; Bianchi M; Serafini G; Stocchi V
    Biomed Biochim Acta; 1990; 49(2-3):S149-53. PubMed ID: 2386500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilar effects of D-mannoheptulose on the phosphorylation of alpha- versus beta-D-glucose by either hexokinase or glucokinase.
    Zhang Y; Courtois P; Sener A; Malaisse WJ
    Int J Mol Med; 2004 Jul; 14(1):107-12. PubMed ID: 15202024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glucose uptake and metabolism in hyperglycemic exacerbation of neurological deficit in the paraplegic rat.
    LeMay DR; Zelenock GB; D'Alecy LG
    J Neurosurg; 1989 Oct; 71(4):594-600. PubMed ID: 2795178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysis.
    de Vooght KM; van Solinge WW; van Wesel AC; Kersting S; van Wijk R
    Haematologica; 2009 Sep; 94(9):1203-10. PubMed ID: 19608687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of oxidized and reduced glutathione on rabbit red blood cell hexokinase.
    Magnani M; Stocchi V; Ninfali P; Dachà M; Fornaini G
    Biochim Biophys Acta; 1980 Sep; 615(1):113-20. PubMed ID: 6968593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Entamoeba histolytica hexokinase 1 inhibitors through homology modeling and virtual screening.
    Saucedo-Mendiola ML; Salas-Pacheco JM; Nájera H; Rojo-Domínguez A; Yépez-Mulia L; Avitia-Domínguez C; Téllez-Valencia A
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):325-32. PubMed ID: 23534932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.